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Background: Stroke is a major cause of death and disability worldwide. Reducing the incidence of stroke has the
potential to not only improve health outcomes, but also lead to significant cost savings for health services.
Transient ischaemic attacks (TIA) can herald an imminent stroke and following a TIA early initiation of best medical
therapy significantly reduces the risk of subsequent stroke. To achieve time targets rapid access stroke specialist
services have been promoted; however, a number of resource related barriers can impede specialist access and
cause unnecessary time delays. Cross sector collaboration led to the development of a primary care based TIA/
Stroke electronic decision support (EDS) tool. This study aimed to assess the impact of this tool on improving
access and reducing management delays.
Methods: This is a prospective before (2009) versus after (2011) study of the effect on process of care following the
implementation of EDS assisted TIA management in primary care. All patients presenting with TIA to secondary
services were included. Outcomes assessed were TIA Guideline adherence and patient safety.
Results: Over the study period 266 patients presented for TIA assessment (130 in 2009 and 136 in 2011). Following
EDS implementation the median delay to specialist assessment fell from 10 days in 2009 to three days in 2011 (HR
1.45; 95% CI 1.13-1.86; p = 0.001), the number of patients achieving optimal medical therapy within 24 hours rose
from 43% to 57% (RR 1.33; 95% CI 1.02-1.71; p = 0.04), carotid and CT imaging were achieved significantly faster (HR
1.52 (1.02-2.26) p = 0.003 and HR 1.34 (1.16-1.78 p = 0.002) respectively), and there were no adverse events
associated with EDS use.
Conclusion: The availability of TIA/Stroke electronic decision support in the primary care setting was associated
with reductions in management delays without compromising patient safety.
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Secondary preventionBackground
Stroke is the third most common cause of death world-
wide, the most common cause of long term adult
disability in developed countries and represents a major
burden on society both in terms of human and health
services costs [1,2]. Ischaemic stroke is caused by an* Correspondence: anna.ranta@otago.ac.nz
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unless otherwise stated.interruption of blood flow to the brain. This is typically
caused by a blood clot, or thrombus, lodged in and
blocking flow through cerebral arteries. Transient is-
chaemic attacks (TIAs) often herald an imminent disab-
ling or fatal stroke [3-5] and early investigation and
initiation of secondary prevention via rapid access spe-
cialist clinics has been shown to substantially reduce this
risk [3,6,7]. However, most TIA and stroke studies come
from tertiary university centres and many areas around
the world struggle to mimic service models as proposedtd. This is an Open Access article distributed under the terms of the Creative
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iety of resource limitations.
In New Zealand, a low population density country, many
rural and smaller urban areas lack the requisite patient vol-
umes and health resources to make rapid (<24 hours) ac-
cess outpatient specialist TIA clinics a feasible option and
admitting all potential TIA patients to the hospital is too
costly and often inappropriate due to a high rate of TIA
mimics [8]. Other barriers to specialist access include geo-
graphical distances, patient financial constraints, as well as
patient preference to be managed by their family doctor. In
settings such as these innovative alternative models of care
require exploration to achieve similar patient outcomes.
Shifting some of the responsibility of caring for these pa-
tients back into the primary care sector is attractive from
an access perspective, however, general practitioner (GPs)
see TIA patients infrequently and may lack the confidence
to initiate management without expert input [9]. The util-
isation of new technologies such as computerised decision
support tools offer an opportunity to provide generalists
with additional support that goes beyond referencing a
guideline. These tools are gaining in popularity throughout
the health sector not only to improve access, but also to
improve overall quality of care and cost-effectiveness [10].
To address the challenge of limited specialist access in
rural and provincial New Zealand MidCentral Health
neurologists collaborated with the primary care driven
Best Practice Advocacy Centre (bpac) to design a TIA/
Stroke Electronic Decision Support (EDS) tool intended
to improve general practitioners’ (GPs) diagnostic accur-
acy, limit emergency department referrals to high risk
patients, and prompt GPs to initiate secondary preven-
tion immediately if specialist review is anticipated to be
delayed or not achievable.
To ensure that the tool sufficiently mimics expert advice
we conducted a study comparing expert, generalist, and
software management of a number of hypothetical cases
which demonstrated a high concordance rate between
majority stroke expert opinion and software advice [9]. In
addition, prior to launching the tool we conducted an eight
week pilot [11] and subsequent to the launch a 14-month
safety audit [12], both of which demonstrated high user
satisfaction and no patient safety concerns. The aim of this
study was to assess if the implementation of a TIA/Stroke
EDS in the primary care setting would be associated with a
reduction of avoidable TIA management delays without
incurring additional patient risk.
Methods
Intervention
The EDS tool consists of a web based single page data
entry form that is completed by the GP (Figure 1). The
computer algorithm incorporates diagnostic criteria and
risk stratification in accordance with the New ZealandTIA guideline [13] as well as expert clinician experience.
Unlike most electronic pathways the algorithm does not
simply follow a vertical electronic flow-chart, but instead
considers and carefully weighs specific clinical informa-
tion provided concurrently to render a decision. This
process aims to more closely mimic the decision making
process of an experienced clinician, which is, in the case
of TIA and many other medical conditions, considerably
more complex than following a flow chart. For example,
if three symptoms are listed one of which is typical for
TIA and two are not clinical judgement has to be
applied to weigh each individual symptoms in order to
decide whether there is enough evidence to make TIA a
likely diagnosis or not. In general, the computer algorithm
errs on the side of over- rather than under-diagnosing
TIAs to minimise risk and in the rare instance where a pa-
tient has no typical symptoms, but is still classed as ‘high
risk’ applying the above criteria the tool still recommends
urgent management. When a diagnosis of TIA or stroke is
deemed likely a management recommendation is rendered
based on risk stratification (Figure 2). A simplified diag-
nostic algorithm is shown in Additional file 1: Figure S1
and additional screenshots showing possible outcome
pages can be viewed in prior publications [14].
Several strategies are in place to encourage GP utilisa-
tion of the tool. Firstly, the tool fully integrates into the
GP electronic medical record system. This allows auto-
matic population of a number of data entry fields with
information previously documented (e.g. past medical
history of atrial fibrillation or diabetes and demographic
data). This avoids duplication and facilitates rapid data
entry. Furthermore, the tool automatically generates spe-
cialist and investigation referrals, pre-populates prescrip-
tions, prints tailored patient information leaflets, and
provides links to additional educational materials. The tool
is also inherently educational by providing the GP with def-
initions for neurological symptoms, guiding them into
obtaining a focussed history and examination, and provid-
ing them with immediate diagnostic feedback. Lastly, by
using the tool the GP may choose to manage the patient
entirely on their own in the community. If the GP chooses
to self manage and the tool supports a diagnosis of TIA
the GP has rapid (<48 hour) access to head computed tom-
ography (CT) and carotid ultrasound (if anatomic localisa-
tion supports a carotid territory TIA). Head CT access is
otherwise generally limited to secondary care physicians in
New Zealand and therefore the use of the tool offers GPs
more autonomy when required. All of these features have
been listed as favourable by surveyed GPs contributing to
general end user uptake [11].
Setting, design, and participants
The TIA/Stroke EDS was assessed in the MidCentral
District Health Board (MDHB) after its launch in late
‘Communication/speech 
problems’ ticked resulting 




Figure 1 TIA/Stroke electronic decision support data entry form depicting a sample case. *PMS = Practice Management System i.e. GP electronic
patient records.
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Figure 2 TIA/Stroke electronic decision support sample outcome page for a low risk patient with typical TIA symptoms.
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mately 170,000 people on New Zealand’s central North
Island. In New Zealand’s public health system all hospital
services, including investigations, are publicly funded and
free of charge to patients. GP visits and prescription
payments are subsidised, but require a co-payment. Some
private specialist services are available although there were
no private stroke service or neurology providers in the
MDHB area during the study periods.
From January 2009 onward we prospectively identified
all patients referred with a diagnosis of ‘TIA’ to the
MidCentral outpatient TIA Clinic or the inpatient Acute
Stroke Service. The study periods were from 1 January
2009 to 30 June 2009 (‘before’ EDS launch) and from 1
January 2011 to 30 June 2011 (‘after’ EDS launch) with
90 day follow-up periods.
Patients who were managed using the EDS, whether
referred to secondary services or not, were independently
identified via bpac’s central database and in addition under-
went detailed primary care record review to screen for any
adverse events that could potentially be linked to EDS use.
The New Zealand National Ethics Committee was
consulted on the project and exempted the study from
a formal ethics review because they considered this
project an audit of an institutional service change.Study outcomes
There were four binary outcomes: 1) achievement of
initiation of best medical therapy (BMT) within 24 hours
of first presentation to a doctor; 2) documentation of
behavioural counseling (including smoking cessation, diet/
exercise, and driving advice); 3) achievement of CT scan; 4)
achievement of carotid imaging. In addition there were
three time-to event outcomes: 1) time to specialist, 2) time
to brain computed tomography (CT), and 3) time to
carotid imaging.
BMT looked at achievement of either anticoagulation
for patients with atrial fibrillation (AF) or implementation
of the combination of: 1) an antiplatelet or antiplatelet
combination (Aspirin monotherapy was considered ac-
ceptable); 2) a statin, and 3) an anti-hypertensive. If a
particular contraindication was listed the drug class was
not required to achieve BMT. Patients who were already
on BMT at the time of presentation were considered to
have achieved BMT within 24 hours.
In addition, EDS safety was assessed by GP and hos-
pital record review for any GP or hospital presenta-
tions that could possibly relate to the use of the EDS
tool (e.g. due to a medication initiated based on EDS
advice, or a mis-diagnosis or incorrect triage advice
rendered by the EDS).
Ranta et al. BMC Family Practice 2014, 15:86 Page 5 of 7
http://www.biomedcentral.com/1471-2296/15/86Data analysis
All categorical data are presented as counts and percent-
ages stratified by study period (2009/2011) and relative
risks were calculated. The significance of association was
assessed using the Chi-squared or the Fisher exact when
the expected or actual cell count was less than five.
Standard methods of survival analysis were used to in-
vestigate time to event outcomes. The unconditional as-
sociation between this measure and the time period was
assessed using the log-rank statistic. Multi-variate mod-
eling was performed to assess for the impact of differ-
ences in baseline characteristics (smoking and ischaemic




In total 236 patients were included in the study: 130 in
2009 and 136 in 2011. All patients carried a referral
diagnosis of ‘TIA’ and were eventually reviewed by a
specialist who rendered a final diagnosis. Table 1 de-
scribes the baseline characteristics of patients at the
initial presentation. A greater percentage of patients had
ischaemic heart disease in 2009 (47% vs 29% ; p = 0.001)
and a greater number of patients had a history of
tobacco use in 2011 (22% vs 49%; p < 0.001). However,
including these parameters in multi-variate modelling
did not impact the significance of the following results.Table 1 Baseline characteristics in patients who
presented to the MidCentral Stroke Service before (2009)
and after (2011) the introduction of a TIA/Stroke decision
support tool
Variable 2009 2011
(n = 130) (n = 136) p-value
Male gender 57 (44) 69 (51) 0.26
Hypertension 88 (69)* 90 (66) 0.68
Diabetes mellitus 23 (18)† 18 (13) 0.34
Atrial fibrillation 34 (27) † 29 (21) 0.28
Ischaemic heart disease 61 (48) † 39 (29) 0.002
Dyslipidaemia 82 (65) † 74 (54) 0.34
Current or ex-smoker 28 (29)‡ 67 (56)§ 0.0002
Stroke risk classified as highf 88 (68) 103 (76) 0.19
Age (years) 0.69
<60 26 (20) 33 (24)
60-79 68 (52) 66 (49)
>=80 36 (28) 37 (27)
Best medical therapy at initial
presentation
47 (36) 43 (32) 0.51
Data are number and percentage. Data missing for * 3, † 4, ‡ 35, and §11
patients. fPatients are classed as ‘high risk’ if they have ongoing stroke
symptoms, an ABCD2 score ≥4, ≥2 events over preceding 7 days, atrial
fibrillation, and/or receive anticoagulation therapy.Best medical therapy was achieved by 43% of patients
in 2009 and 57% in 2011 (Relative Risk (RR) 1.33; 95%
Confidence Interval (CI) 1.02-1.7; p = 0.04) and behav-
ioural counseling was provided to 40% of patients in
2009 and 66% of patients in 2011 (RR 1.68; 95% CI 1.31-
2.16; p < 0.0001) (Table 2).
The time from first point of contact (FPC) until stroke
specialist review was significantly shorter in 2011 than
2009 (p = 0.001; Figure 3). In 2011 the median time from
FPC to specialist was 10 days which decreased to three
days in 2011 (Hazard ratio (HR) 1.45; 95% CI 1.13-1.86).
Patients seen in 2011 were 1.3 times (95% CI 1.07 -
1.59) more likely to have a CT scan than those seen in
2009 (p = 0.006; Table 1) and the median time till a CT
scan was performed reduced from 2 days in 2009 to
1 day in 2011 (HR 1.34; 95% CI 1.16-1.78; p = 0.002;
Figure 3). Similarly patients seen in 2011 were 1.7
(95% CI 1.25 - 2.3) more likely than patients seen in
2009 to have carotid imaging (p = 0.0006) and time to
carotid imaging reduced from 24 days in 2009 to 7 days
in 2011 (HR 1.52; 95% CI 1.02-2.26; p-value = 0.003;
Figure 3).
Safety
During the 2011 study period, five patients represented to
hospital within 90 days of receiving EDS assisted manage-
ment. Admission diagnoses included: hip fracture due to
falls attributed to postural hypotension (unrelated to recent
medication initiation), elective management of a patent
foramen ovale (without recurrent TIA/stroke), bronchitis,
astrocytoma, and migraine. While some of these diagnoses
were related to the patients’ original ‘TIA’ presentation in
no instance were these admissions adversely related to mis-
diagnosis or inappropriate management recommendations
by the TIA EDS. There were no instances of even minor
medication related adverse events or treatment delays due
to EDS misdiagnosis or inappropriate triage advice. There
were no cases of recurrent TIA or stroke amongst patients
triaged as ‘low risk’ while awaiting outpatient specialist re-
view. Similarly patients diagnosed as ‘non-TIA’ by the tool
did not present with any subsequent cerebrovascular
events.Table 2 Primary outcomes before (2009) and after (2011)
the introduction of a TIA/Stroke decision support tool
Variable 2009 2011 Relative risk P-value
(n = 130) (n = 136) (95% CI)
BMT within 24 hours 51 (43)† 71 (57) § 1.33 (1.02 - 1.71) 0.04
Behavioural
counselling
51 (40)* 77 (66)‡ 1.68 (1.31 - 2.16) <0.0001
CT scan 93 (72) 117 (86) 1.3 (1.07 - 1.59) 0.006
Carotid imaging 40 (31) 71 (52) 1.7 (1.25 - 2.3) 0.0006
Data are number and percentage. Data missing for †11, §6, *1, and
‡20 patients.
Figure 3 Kaplan-Meier estimate of the days from first point of contact (FPC) to review by a specialist (A), CT imaging (B), and carotid
imaging (C) before (2009) and after (2011) the introduction of a TIA/Stroke electronic decision support tool.
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We describe the first application of an electronic deci-
sion support tool in the primary care setting to aid in
the management of TIA and minor strokes. This ‘Before
and After’ study suggests that the implementation of this
tool was associated with a significant improvement in
the rate of rapid initiation of best medical TIA therapy,
which has previously been shown to significantly reduce
recurrent stroke [8]. In addition to earlier medication initi-
ation we also observed a reduction in time delays to special-
ist review and relevant imaging. Furthermore, behavioural
counseling and overall rate of diagnostic imaging acquisition
improved after the tool was implemented.
Our data also suggest that this tool is safe. There were
no cases of inappropriate diagnosis, triage, or manage-
ment advice resulting in adverse events. Patients diag-
nosed as ‘non-TIAs’ did not experience any later recurrent
TIAs or strokes and patients triaged as ‘low risk’ did not
experience any recurrent TIAs or strokes while awaiting
specialist review.
This study has clear limitations given its non-randomised
observational design. While our comparison groups were
identified prospectively and included all patients presentingto stroke specialists in the entire study population there
remains a potential that some patients were missed because
they were never referred to secondary care. There were also
some baseline differences between groups: there was a
higher prevalence of ischaemic heart disease in the 2009
and tobacco use in 2011. However, results remained signifi-
cant even after adjusting for these potential confounders.
As regards other potential service related confounders it is
important to note that there were no changes relating to
referral processing, admission criteria, appointment book-
ing, diagnostic access, or neurology and radiology staff
numbers between the two study periods. Nonetheless, des-
pite our efforts to control for any changes other than the
introduction of the TIA/Stroke EDS between study periods
unrecognised confounders cannot, of course, be excluded
in this type of study. For example, the promotion of the
tool itself and wide dissemination of national TIA best prac-
tice guideline may have progressively raised TIA awareness
throughout the district resulting in a general improvement
in TIA care over time. A final limitation is that this study
does not provide information about the impact of the tool
on actual patient outcomes such as 90-day stroke risk.
Complete 90-day follow-up data was not available for this
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the tool’s impact on stroke recurrence. However, results
from a multi-centre cluster randomised controlled trial,
specifically designed to assess the tool’s impact on patient
outcomes, will be available later this year and will provide
further information [14].
Conclusion
This cross-sectoral collaborative implementation of a TIA/
Stroke EDS was associated with an improvement in TIA
guideline adherence and a reduction in avoidable manage-
ment delays, which have previously been linked to improved
stroke outcomes and reduced health care costs. While our
study design precludes us from asserting a clear causative
link the findings nonetheless suggest that this type of health
service provision may represent a feasible option to improve
primary/secondary integration and improve overall TIA
management and stroke prevention especially. This model
would be particularly applicable in areas where more trad-
itional models of care are difficult to replicate due to health
resource limitations or geographical/cultural barriers imped-
ing rapid specialist access. Results from a more definitive
randomised controlled trial testing the efficacy and safety of
this tool will be forthcoming later this year (FASTEST Trial
ACTRN12611000792921).
Additional file
Additional file 1: Figure S1. Simplified TIA/stroke electronic decision
support TIA diagnostic algorithm (excludes stroke and several more
complex diagnostic features) [15].
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